NCT06068374

Breaks From Sedentary Behavior With Dual Tasks in Elderly

Acute Effects of Breaks From Sedentary Behavior With Dual Tasks on Cerebral Blood Flow, Cognitive Function, Blood Pressure and Vascular Function in the Elderly
University of Nove de Julho·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Aging
Drug/Device/Intervention
Break of sedentary behavior with dual task
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Nove de Julho
Location
São Paulo, Brazil
Timeline & enrollment
Phase
N/A
Start date
Feb 27, 2023
End date
Jul 31, 2024
Enrollment
22 participants
Primary outcome

Cerebral blood velocity [centimeters per second],Cognitive function - The Trail Making Tests [seconds],Cognitive function - Stroop test [seconds],Cognitive function - verbal fluency [number of animal names reported]

Summary

The aim of this project will be to compare the acute effects of breaks from sedentary
 behavior using dual-tasking on cerebral blood flow, vascular function, cognitive functions
 and blood pressure in elderly people. Participants will perform, in random order, three
 experimental sessions (control, break with dual-task and standard break ([walk]). All
 sessions will have a period of 4 hours in sedentary behavior. In the standard break session
 and in the break session with dual-task participants will take walking and dual-task breaks
 every 30 minutes, and in the control session they will remain seated without breaks. Before
 and after this period, cerebral blood flow, vascular function, cognitive functions and blood
 pressure will be assessed.

ICD-10 classifications
Alzheimer diseaseAgenesis and underdevelopment of noseAgenesis of lungAdult-onset Still diseaseChoroidal degeneration
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06068374
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06068374 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nove de Julho and is currently Recruiting. The study focuses on Aging. Target enrollment is 22 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.